Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 11
51
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver

, , , , &
Pages 1097-1108 | Received 02 May 2003, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Naoki Kamada, Keigo Yamada, Masaaki Odomi, Tadashi Mukai, Toru Nishibayashi, Ken-ichi Ogawara, Toshikiro Kimura & Kazutaka Higaki. (2011) Sex differences in pharmacokinetics of cilostazol in rats. Xenobiotica 41:10, pages 903-913.
Read now

Articles from other publishers (4)

Keita Yamanouchi, Tomoki Ishimaru, Takuya Kakuno, Yuki Takemoto, Sho Kawatsu, Keiji Kondo, Masato Maruyama & Kazutaka Higaki. (2023) Improvement and characterization of oral absorption behavior of clofazimine by SNEDDS: Quantitative evaluation of extensive lymphatic transport. European Journal of Pharmaceutics and Biopharmaceutics 187, pages 141-155.
Crossref
Chikako Imada, Takuma Takahashi, Makoto Kuramoto, Kazufumi Masuda, Ken-ichi Ogawara, Akira Sato, Yusuke Wataya, Hye-Sook Kim & Kazutaka Higaki. (2015) Improvement of Oral Bioavailability of N-251, a Novel Antimalarial Drug, by Increasing Lymphatic Transport with Long-Chain Fatty Acid-Based Self-Nanoemulsifying Drug Delivery System. Pharmaceutical Research.
Crossref
Hirotaka Miyamoto, Satoshi Matsueda, Kotaro Komori, Shintaro Fumoto, Mikiro Nakashima, Naoki Yoshikawa, Haruna Hirata, Kenta Shimokawa, Yuichi Ohwaki & Koyo Nishida. (2013) Evaluation for effect of hypothermia on the disposition of 4-nitrophenol in rats by in-vitro metabolism study and rat liver perfusion system. Journal of Pharmacy and Pharmacology 65:10, pages 1536-1540.
Crossref
Pallabi Mitra & Kenneth L. Audus. (2010) MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells. International Journal of Pharmaceutics 384:1-2, pages 15-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.